Clareon PanOptix Pro vs. Clareon PanOptix - Study B

NACompletedINTERVENTIONAL
Enrollment

161

Participants

Timeline

Start Date

June 18, 2024

Primary Completion Date

December 13, 2024

Study Completion Date

April 30, 2025

Conditions
AphakiaPresbyopia
Interventions
DEVICE

CPO Pro IOL

Intraocular lens (IOL) implanted in the eye for the visual correction of aphakia in adult patients with less than 1 diopter of preexisting corneal astigmatism in whom a cataractous lens has been removed. The IOL is intended to mitigate the effects of presbyopia on intermediate and near visual acuity while maintaining comparable distance visual acuity.

DEVICE

CPO IOL

Intraocular lens (IOL) implanted in the eye for the visual correction of aphakia in adult patients with less than 1 diopter of preexisting corneal astigmatism in whom a cataractous lens has been removed. The IOL is intended to mitigate the effects of presbyopia on intermediate and near visual acuity while maintaining distance visual acuity.

PROCEDURE

Cataract Surgery

Extraction of the cataractous lens by phacoemulsification, followed by implantation of the IOL.

Trial Locations (8)

29414

Carolina Eye Care Physicians, Charleston

37205

Vision for Life, Nashville

45242

Cincinnati Eye Institute, Cincinnati

48302

Grosinger, Spigelman & Grey Eye Surgeons, P.C., Bloomfield Hills

64154

Moyes Eye Center, Kansas City

77008

Houston Eye Associates, Houston

84107

The Eye Institute of Utah, Salt Lake City

90505

Wolstan & Goldberg Eye Associates, Torrance

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Alcon Research

INDUSTRY